Journal article
Long-term prognostic value of contemporary stress echocardiography in patients with suspected or known coronary artery disease: systematic review and meta-analysis
- Abstract:
- Background: Long-term outcome of contemporary stress echocardiography has not been systematically assessed. Objective: To evaluate the association between results of stress echocardiography and patients’ outcomes with suspected coronary artery disease using randomised controlled trials. Methods: Multiple electronic databases were searched for studies evaluating long-term outcome (>12 months) of stress echocardiography in patients suspected of coronary artery disease since year 2000. A common-effect model was used to derive pooled estimates. The primary outcome was a composite of all-cause mortality or cardiovascular death and non-fatal myocardial infarction, depending on the definition applied in individual trials, termed as major adverse cardiovascular event (MACE). Secondary outcome was all-cause mortality. Positive stress echocardiography result was defined as inducible ischaemia in at least one of the 17 left ventricular segments and negative stress echocardiography with no inducible ischaemia. Results: Among a total of six trials, 16 581 subjects underwent either pharmacological or treadmill stress echocardiography, a median follow-up of 31 months (range 21–101). The annual event rate was 1.76% for the composite MACE and 1.35% for all-cause mortality. Compared with negative stress echocardiography, positive stress echocardiography was associated with an increased risk of the MACE and all-cause mortality with an annual event rate of 1.99% vs 1.54% (OR 2.04, 95% CI 1.79 to 2.33) and 1.68% vs 1.02% (OR 2.06, 95% CI 1.80 to 2.35), respectively. Conclusion: Positive stress echocardiography results were associated with poorer long-term MACE and all-cause mortality. Stress echocardiography results may provide a useful long-term guidance in intensifying preventative treatment in patients with suspected coronary artery disease. PROSPERO registration number: CRD42023416766.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of Record, Version of record, pdf, 1.5MB, Terms of use)
-
- Publisher copy:
- 10.1136/heartjnl-2024-324534
Authors
- Publisher:
- BMJ Publishing Group
- Journal:
- Heart More from this journal
- Article number:
- heartjnl-2024-324534
- Publication date:
- 2024-08-23
- Acceptance date:
- 2024-07-31
- DOI:
- EISSN:
-
1468-201X
- ISSN:
-
1355-6037
- Language:
-
English
- Keywords:
- Pubs id:
-
2289258
- Local pid:
-
pubs:2289258
- Source identifiers:
-
2220439
- Deposit date:
-
2024-08-28
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2024
If you are the owner of this record, you can report an update to it here: Report update to this record